| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/19/2007 | WO2007033020A3 Ophthalmic formulation for treatment of dry eye |
| 07/19/2007 | WO2007015824A3 Novel macrocyclic inhibitors of hepatitis c virus replication |
| 07/19/2007 | WO2007013124A3 Stimulatory auto-antibodies to the pdgf receptor as pathology marker and therapeutic target |
| 07/19/2007 | WO2007001406A3 Aryl-containing macrocyclic compounds |
| 07/19/2007 | WO2007000347A3 Agonistic and antagonistic peptide mimetics of the vegf alpha-helix binding region for use in therapy |
| 07/19/2007 | WO2006138238A3 Methods of protecting against apoptosis using lipopeptides |
| 07/19/2007 | WO2006133523A3 Improved antimicrobial peroxidase compositions |
| 07/19/2007 | WO2006128083A3 Human proislet peptide, derivatives and analogs thereof, and methods of using same |
| 07/19/2007 | WO2006124667A3 Compositions and methods for modulating immune responses |
| 07/19/2007 | WO2006120038A3 Use of native peptides and their optimized derivatives for vaccination |
| 07/19/2007 | WO2006079120A3 Fc-fusion constructs binding to phosphatidylserine and their therapeutic use |
| 07/19/2007 | WO2006078783A3 Htm4 used for cell-cycle regulation through its interaction with kap |
| 07/19/2007 | WO2006066024A8 Pancreatic polypeptide family motifs, polypeptides and methods comprising the same |
| 07/19/2007 | WO2006050159A3 Methods of predicting responsiveness to treatment |
| 07/19/2007 | WO2005120546A3 Compositions and methods for topical diagnostic and therapeutic transport |
| 07/19/2007 | WO2005089805A3 Polymer-based compositions and conjugates of hiv entry inhibitors |
| 07/19/2007 | WO2005084184A3 Methods for enhancing learning and memory |
| 07/19/2007 | WO2004100886A3 POLYNUCLEOTIDES AND POLYPEPTIDES ASSOCIATED WITH THE NF-kB PATHWAY |
| 07/19/2007 | WO2003054144A8 Human ras interacting protein |
| 07/19/2007 | WO2003035847A3 Il-13 mutein proteins, antibodies, compositions, methods and uses |
| 07/19/2007 | WO2001087917A8 Novel nucleic acids and polypeptides |
| 07/19/2007 | US20070169211 Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof |
| 07/19/2007 | US20070169210 Modulators of gamete adhesion include polypeptides comprising at least one discoidin/C domain and optionally EGF domain; medical diagnosis; contraception; fertility |
| 07/19/2007 | US20070167644 Bifunctional energy-reversible acyl-compositions |
| 07/19/2007 | US20070167611 Peptides and Peptidomimetics with Structural Similarity to Human p53 that Activate p53 Function |
| 07/19/2007 | US20070167607 Use of soluble forms of cd83 and nucleic acids encoding them for the treatment or prevention of diseases |
| 07/19/2007 | US20070167504 Viral hepatitis treatment |
| 07/19/2007 | US20070167405 Galectins -1 and -4 in tumor development |
| 07/19/2007 | US20070167393 RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA) |
| 07/19/2007 | US20070167386 Remedy for cardiac failure containing ask1 inhibitor as active ingredient and method for screening the same |
| 07/19/2007 | US20070167385 for treatment of chronic inflammatory bowel disease, Crohn's disease and ulcerative colitis |
| 07/19/2007 | US20070167380 Taste masked compositions of erythromycin a and derivatives thereof |
| 07/19/2007 | US20070167377 Inhibitors of glycinamide ribonucleotide transformylase |
| 07/19/2007 | US20070167376 Hexa-, Hepta-, and Octapeptides Having Antiangiogenic Activity |
| 07/19/2007 | US20070167375 HLA (human leukocyte antigen)-A2-restricted cytotoxic T lymphocyte (CTL) epitope derived from the interleukin (IL)-13 receptor (R) alpha 2; Eph family of tyrosine kinase receptors |
| 07/19/2007 | US20070167374 Specific antagonists for glucose-dependent insulinotropic polypeptide (GIP) |
| 07/19/2007 | US20070167373 Combined use of a GLP-1 compound and a modulator of diabetic late complications |
| 07/19/2007 | US20070167372 Ocular tear growth factor-like protein |
| 07/19/2007 | US20070167371 Treating deficient tear output and enhancing the proliferation of human corneal epithelial cells by contacting the ocular surface or the cells with a lacrimal gland protein that has activity as a growth factor on both human corneal epithelial cells and on the lacrimal acinar cells that produce it. |
| 07/19/2007 | US20070167370 Peptide analogues of GIP for treatment of diapetes, insulin resistance and obesity |
| 07/19/2007 | US20070167369 Novel use of isolated polypeptide comprising four FAS-1 domains, EM1 domain and RGD motif |
| 07/19/2007 | US20070167368 Dried blood factor composition comprising trehalose |
| 07/19/2007 | US20070167367 Heterodimeric four helix bundle cytokines |
| 07/19/2007 | US20070167366 Peptide with putative role in cytoskeletal protection |
| 07/19/2007 | US20070167365 Compositions and methods for modulating blood-brain barrier transport |
| 07/19/2007 | US20070167364 Compositions and methods for enhanced mucosal delivery of parathyroid hormone |
| 07/19/2007 | US20070167363 Peptide fragments and optionally excipients, used for prophylaxis of obesity and non-insulin dependent diabetes; antagonist of glucose-dependent insulinotropic polypeptide (GIP) consisting of a 24 amino acid polypeptide corresponding to positions 7-30 of the sequence of GIP |
| 07/19/2007 | US20070167362 Medicines containing nerve growth factor for assisting losing weight and methods for assisting losing weight using same |
| 07/19/2007 | US20070167361 Use of factor XIII for stimulating the perfusion of ischemic tissue |
| 07/19/2007 | US20070167360 Methods for treating multiple sclerosis |
| 07/19/2007 | US20070167359 Pharmaceutical composition comprising proteins and/or polypeptides and colloidal particles |
| 07/19/2007 | US20070167358 Prevention and treatment of ocular side effects with a cyclosporin |
| 07/19/2007 | US20070167357 Dab9 DERIVATIVES OF LIPOPEPTIDE ANTIBIOTICS AND METHODS OF MAKING AND USING THE SAME |
| 07/19/2007 | US20070167356 Glycosulfopeptide inhibitors of leukocyte rolling and methods of use thereof |
| 07/19/2007 | US20070167355 Dietary and pharmaceutical compositions for management and treatment of oxidative stress |
| 07/19/2007 | US20070167354 Hydrogels for modulating cell migration and matrix deposition |
| 07/19/2007 | US20070167353 Prodrug composition |
| 07/19/2007 | US20070167352 preparing an oxygenated hemoglobin solution; thiolating with 2-iminothiolane to form thiolated oxygenated hemoglobin;reacting intermediate with maleimidyl polyethylene glycol to form polyethylene glycol modified hemoglobin; autooxidation resistance; superior oxygen transporter |
| 07/19/2007 | US20070167351 Peptide/Lipid Complex Formation by Co-Lyphilization |
| 07/19/2007 | US20070167350 Quinaldine based semisquaraines and squaraine dyes, process for preparation thereof and use thereof |
| 07/19/2007 | US20070167349 Estrogen cancer therapy |
| 07/19/2007 | US20070166824 Manipulation of non-terminally differentiated cells using the notch pathway |
| 07/19/2007 | US20070166813 Gaucher disease drugs and methods of identifying same |
| 07/19/2007 | US20070166796 Il-21 antagonists |
| 07/19/2007 | US20070166795 Cytokine-like proteins |
| 07/19/2007 | US20070166794 Cytokine zalpha11 ligand fusion proteins |
| 07/19/2007 | US20070166790 Derivatives of magainin and methods of production thereof |
| 07/19/2007 | US20070166789 polynucleotide comprising a DNA sequence that codes for a polypeptide having oxidoreductase enzyme activity, used in detection assays, gene therapy, and screening assays |
| 07/19/2007 | US20070166787 Modulators of regulatory proteins |
| 07/19/2007 | US20070166757 Relaxin as an independent risk factor predicting mortality |
| 07/19/2007 | US20070166756 Polypeptides and polynucleotides encoding same |
| 07/19/2007 | US20070166753 Gene detection assay for improving the likelihood of an effective response to a her2 antibody cancer therapy |
| 07/19/2007 | US20070166746 Human cytokine receptor |
| 07/19/2007 | US20070166737 Survival motor neuron (SMN) gene: a gene for spinal muscular atrophy |
| 07/19/2007 | US20070166711 Juvenile hemochromatosis gene (hfe2a), expression products and uses thereof |
| 07/19/2007 | US20070166710 Methods for inhibiting adipogenesis and for treating type 2 diabetes |
| 07/19/2007 | US20070166368 Protein-Stabilized Liposomal Formulations of Pharmaceutical Agents |
| 07/19/2007 | US20070166367 Adept or gdept producing acetaldehyde |
| 07/19/2007 | US20070166352 polyglycolic acid or polylactic acid or glycolic acid-lactic acid copolymer as biocompatible polymer having dispersed therein an active agent such as exendin-4; antidiabetic agent |
| 07/19/2007 | US20070166351 Polycationic peptides for cardiovascular therapy |
| 07/19/2007 | US20070166348 Keratin bioceramic compositions |
| 07/19/2007 | US20070166343 Matrix, cell implantation and method for their production and use |
| 07/19/2007 | US20070166331 Modified seb and prophylactics/remedies for immunopathy containing the same |
| 07/19/2007 | US20070166310 prostate cancer and benign prostatic hyperplasia; promote tissue regeneration and to facilitate wound healing |
| 07/19/2007 | US20070166299 Treatment for embolic stroke |
| 07/19/2007 | US20070166298 Formulations for the rectal administration of thrombolytically-active agents |
| 07/19/2007 | US20070166297 Human analogs of murine deubiquitinating protease |
| 07/19/2007 | US20070166296 Therapeutic Systems |
| 07/19/2007 | US20070166285 Systems and methods related to degradation of uremic toxins |
| 07/19/2007 | US20070166284 Therapeutic regimen for treating cancer |
| 07/19/2007 | US20070166283 Compositions and methods for the treatment of hemophilia a |
| 07/19/2007 | US20070166282 Homogeneous preparations of IL-28 and IL-29 |
| 07/19/2007 | US20070166281 Chloroquine coupled antibodies and other proteins with methods for their synthesis |
| 07/19/2007 | US20070166280 Chemokines as adjuvants of immune response |
| 07/19/2007 | US20070166279 Method for modulating hla class ii tumor cell surface expression with a cytokine mixture |
| 07/19/2007 | US20070166278 Novel g-csf conjugates |
| 07/19/2007 | US20070166276 Useful in extending the in vivo circulating life of biologically active materials; bicine linker allows for the manipulation of the hydrolysis rate of the prodrug, thereby releasing the native entities at various rates in vivo as well as in vitro |
| 07/19/2007 | US20070165829 Personal Communication Center Performance Display and Status Alert System |
| 07/19/2007 | CA2657683A1 Cystine-knot fold cytokine |
| 07/19/2007 | CA2637377A1 Template-fixed peptidomimetics with antimicrobial activity |